Polymorphic transitions of cimetidine during manufacture of solid dosage forms
- 1 August 1996
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 140 (2) , 195-206
- https://doi.org/10.1016/0378-5173(96)04587-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The polymorphism of cimetidineJournal of Pharmaceutical and Biomedical Analysis, 1985
- Dissolution behavior and bioavailability of cimetidine-HCl (cimetidine monohydrochloride monohydrate)International Journal of Pharmaceutics, 1985
- Effect of grinding on the transformations of polymorphs of chloramphenicol palmitate.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- Polymorphic Transformation of Some Drugs Under CompressionDrug Development and Industrial Pharmacy, 1985
- Crystal and molecular structure of 4-[2-(2-cyano-3-methyl-3-nitroso-1-guanidino)ethylthiomethyl]-5-methylimidazolium nitrate (N-nitrosocimetidine nitrate)Journal of the Chemical Society, Perkin Transactions 2, 1983
- Copper(II) complexes of the antiulcer drug cimetidineJournal of the American Chemical Society, 1980
- 2-Cyano-1-methyl-3-{2-[(5-methyl-1H-imidazol-4-yl)methylthio]-ethyl}guanidine monohydrateActa Crystallographica Section B: Structural Science, Crystal Engineering and Materials, 1980
- Die Struktur von Cimetidin (N″‐Cyan‐N‐Methyl‐N′‐[2‐[(5‐methyl‐1H‐imidazol‐4‐yl)methylthio]ethyl]guanidin), einem Histamin H2‐Rezeptor‐AntagonistEuropean Journal of Inorganic Chemistry, 1978
- Pharmacological evaluation of cimetidine, a new histamine H2‐receptor antagonist, in healthy man.British Journal of Clinical Pharmacology, 1975
- Pharmaceutical Applications of PolymorphismJournal of Pharmaceutical Sciences, 1969